Outcome | N | OR | 95% CI | p |
---|
ASAS20 | 89 | 0.20 | 0.06; 0.62 | 0.008 |
ASAS40 | 89 | 0.25 | 0.07; 0.78 | 0.02 |
BASDAI50 | 89 | 0.24 | 0.07; 0.72 | 0.01 |
ASDAS improvement ≥ 1.1 | 78 | 0.32 | 0.10; 0.93 | 0.04 |
ASDAS < 2.1 | 82 | 0.26 | 0.06; 0.91 | 0.04 |
ASDAS improvement ≥ 2 | 78 | 0.08 | 0.01; 0.43 | 0.006 |
ASDAS < 1.3 | 82 | 0.14 | 0.02; 0.62 | 0.02 |
- Analyses are adjusted for diagnostic delay, MASES, BASDAI, and BMI. ASAS20 and ASAS40 20% and 40% improvement according to the ASAS criteria, respectively; ASDAS Ankylosing Spondylitis Disease Activity Score; BASDAI50 50% improvement in the BASDAI; nr-axSpA nonradiographic axial spondyloarthritis; TNF tumor necrosis factor